2025
Nonpharmacologic Interventions to Improve Postural Control Among Breast Cancer Survivors With Chemotherapy-induced Neuropathy
Luciani B, Schnell P, Bland C, Wilder J, Lantis K, Hock K, Hackney M, Lustberg M, Worthen-Chaudhari L. Nonpharmacologic Interventions to Improve Postural Control Among Breast Cancer Survivors With Chemotherapy-induced Neuropathy. Archives Of Physical Medicine And Rehabilitation 2025, 106: e130-e131. DOI: 10.1016/j.apmr.2025.01.338.Peer-Reviewed Original ResearchPostural control improvementHome exercisesActivity-based interventionsPostural controlBC survivorsNonpharmacological interventionsHome exercise groupImprove postural controlPostural control deficitsBreast cancer survivorsMeasure postural controlMonths follow-upChemotherapy-induced neuropathyWeeks of interventionBreast cancerMain outcome measuresBilateral standingCancer survivorsFall riskCourse of interventionIntervention effectsTango danceLinear mixed modelsBiomechanical measuresOutcome measures
2024
Neurologic dance training and home exercise improve motor-cognitive dual-task function similarly, but through potentially different mechanisms, among breast cancer survivors with chemotherapy-induced neuropathy: Initial results of a randomized, controlled clinical trial
Worthen-Chaudhari L, Crasta J, Schnell P, Lantis K, Martis J, Wilder J, Bland C, Hackney M, Lustberg M. Neurologic dance training and home exercise improve motor-cognitive dual-task function similarly, but through potentially different mechanisms, among breast cancer survivors with chemotherapy-induced neuropathy: Initial results of a randomized, controlled clinical trial. Journal Of Alzheimer’s Disease 2024, 105: 1114-1130. PMID: 39584292, DOI: 10.1177/13872877241291440.Peer-Reviewed Original ResearchDual-task functionSurvivors of BCHome exercisesParticipants' ratings of perceived exertionSurvivors of breast cancerRating of perceived exertionTimed-Up-and-GoBreast cancer survivorsChemotherapy-induced neuropathyWeeks of interventionBreast cancerConventional exerciseDual-task performanceCancer survivorsIntervention adherencePhysical activityDance interventionAlzheimer's diseaseProdromal Alzheimer's diseaseSocial dancePhysical exertionParticipation ratesExerciseMonths follow-upFeasibility criteria
2023
Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan
Winters M, Christie S, Lepage C, Malik A, Bokemper S, Abeyesekera S, Boye B, Moini M, Jamil Z, Tariq T, Beresh T, Kazymyrova G, Palamar L, Paintsil E, Faller A, Seusan A, Bonnevie E, Smyser J, Khan K, Gulaid M, Francis S, Warren J, Thomson A, Omer S. Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan. PLOS Global Public Health 2023, 3: e0002357. PMID: 37756298, PMCID: PMC10529538, DOI: 10.1371/journal.pgph.0002357.Peer-Reviewed Original ResearchVaccine uptakeVaccination coverageCOVID-19 vaccination campaignCOVID-19 vaccine uptakeMessaging campaignsWeeks of interventionCOVID-19 vaccination dataPoisson regression modelsVaccination statusPre-post designVaccination dataVaccination intentionVaccination campaignTime pointsWeeksInterventionRCTsVaccineImportant predictorRegression modelsOffline effectsRobust evidenceUptakeTrialsEffect of the glucagon‐like peptide‐1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes
Silver H, Olson D, Mayfield D, Wright P, Nian H, Mashayekhi M, Koethe J, Niswender K, Luther J, Brown N. Effect of the glucagon‐like peptide‐1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes. Diabetes Obesity And Metabolism 2023, 25: 2340-2350. PMID: 37188932, PMCID: PMC10544709, DOI: 10.1111/dom.15113.Peer-Reviewed Original ResearchMeSH KeywordsAdultAppetiteBody Fat DistributionBody WeightCaloric RestrictionCardiovascular DiseasesDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsDipeptidyl-Peptidases and Tripeptidyl-PeptidasesEatingGlucagon-Like Peptide-1 ReceptorHumansHypoglycemic AgentsLiraglutideObesityPrediabetic StateSitagliptin PhosphateWeight LossConceptsGlucagon-like peptide-1 receptor agonist liraglutidePeptide-1 receptor agonist liraglutideLiraglutide groupSitagliptin groupCR groupCaloric restrictionChi-squared testDietary intakeWeight lossBody weightBody compositionDipeptidyl peptidase-4 inhibitor sitagliptinDipeptidyl peptidase-4 inhibitorsDual-energy X-ray absorptiometryEnergy X-ray absorptiometryInsulin resistance scoreBaseline body weightHomeostatic model assessmentPeptidase-4 inhibitorsCardiometabolic risk reductionBody fat distributionVisual analog scaleWeeks of interventionPersonal risk factorsX-ray absorptiometry
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply